PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
Fiche publication
Date publication
mars 2024
Journal
Cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CHAIGNEAU Loïc, Pr KURTZ Jean-Emmanuel, Pr MALOUF Gabriel, Dr HERVIEU Alice, Dr CHARON-BARRA Céline, Dr GANTZER Justine
Tous les auteurs :
Gantzer J, Toulmonde M, Severac F, Chamseddine AN, Charon-Barra C, Vinson C, Hervieu A, Bourgmayer A, Bertucci F, Ryckewaert T, Valentin T, Firmin N, Chaigneau L, Bompas E, Follana P, Rioux-Leclercq N, Soibinet-Oudot P, Bozec L, Le Loarer F, Weingertner N, Chevreau C, Duffaud F, Blay JY, Kurtz JE, Schöffski P, Brahmi M, Malouf GG
Lien Pubmed
Résumé
Perivascular epithelioid cell neoplasms (PEComas) encompass a heterogeneous family of mesenchymal tumors. Previously described clinicopathologic features aimed at distinguishing benign from malignant variants but lacked prognostic value.
Mots clés
necrosis, perivascular epithelioid cell neoplasms (PEComas), positive margins, prognostic, sex, vascular invasion
Référence
Cancer. 2024 03 12;: